DPP4 and diabetes mellitus: Based on this, the primary objectives of this study were to identify natural and safe therapeutic agents for diabetes by elucidating the residue basis and conformational changes underlying the interactions between DPP-4 and its inhibitory peptides, as well as to present an integrated computational pipeline to screen and identify DPP-4 inhibitory peptides.